Metrics
Publication
219
Open Access
25
UN Sustainable Development Goals
Announcements & Documents
Download File
Education
1999 - 2002
1999 - 2002Post Doctorate of Medicine
Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Turkey
1994 - 1999
1994 - 1999Expertise In Medicine
Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Turkey
1987 - 1993
1987 - 1993Undergraduate
Hacettepe University, Tıp Fakültesi, Tıp Pr., Turkey
Dissertations
2002
2002Post Doctorate of Medicine
Endoskopi ünitesine başvuran hastalarda barrett özofagusu sıklığı ve üst gastrointestinal semptomlarla olan ilişkisi
Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
1999
1999Expertise In Medicine
Hepatik ensefalopatili bir hayvan modelinde opioderjik sistem aktivitesi ölçüsü olarak adenilat siklaz enzim aktivitesinin incelenmesi
Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Foreign Languages
C1 Advanced
C1 AdvancedEnglish
Research Areas
Avesis Research Areas:
Medicine, Internal Medicine Sciences, Internal Diseases, Gastroenterology and Hepatology, Health Sciences
WoS Research Areas:
Gastroenterology & Hepatology, Clinical Medicine, Clinical Medicine (Med)
Scopus Research Areas:
Gastroenterology
Research Areas Based on Academic Activities
Avesis Research Areas
WoS Research Areas
Scopus Research Areas
Academic Positions
2010 - Continues
2010 - ContinuesProfessor
Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2005 - 2010
2005 - 2010Associate Professor
Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2003 - 2005
2003 - 2005Research Assistant
Mayo Clinic, School Of Medicine, Department Of Gastroenteroloji
2002 - 2005
2002 - 2005Expert
Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
1999 - 2002
1999 - 2002Expert
Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
1994 - 1999
1994 - 1999Research Assistant
Ankara University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
1997 - 1998
1997 - 1998Research Assistant
Yale University, Üretim Yönetimi, Hepatik Hemodinamik Laboratuvar
Managerial Experience
2008 - 2012
2008 - 2012Vice Dean
Ankara University
Supervised Theses
2023
2023Expertise In Medicine
Biyolojik ajan kullanan inflamatuar barsak hastalarında primer ve sekonder yanıtsızlık oranları ve bu oranlar üzerinde etkili faktörler
Törüner M. (Advisor)
Z.EROĞLU(Student)
2017
2017Expertise In Medicine
İnflamatuvar barsak hastalığı'nda sitomegalovirus (CMV) enfeksiyonu sıklığı, risk faktörleri ve klinik seyir
TÖRÜNER M. (Advisor)
B.MANTI(Student)
2015
2015Expertise In Medicine
İnflamatuar barsak hastalığı olan bireylerde hastalık tipi, aktivitesinin cinsel yaşantı ve hayat kalitesi üzerine etkisi
TÖRÜNER M. (Advisor)
E.BULUT(Student)
2011
2011Expertise In Medicine
Kolorektal kanserlerde vitamin D reseptör ekspresyonunun kolorektal kanserlerde evre ile ilişkisi ve prognoz üzerine etkisi
TÖRÜNER M. (Advisor)
M.SEZGİN(Student)
2011
2011Expertise In Medicine
İltihabi barsak hastalıklarında interlökin 23 reseptör ve atg16l1 gen polimorfizmleri ve klinikle ilişkisi
TÖRÜNER M. (Advisor)
G.KABAÇAM(Student)
Articles
All (148)
SCI-E, SSCI, AHCI (138)
SCI-E, SSCI, AHCI, ESCI (140)
ESCI (2)
Scopus (145)
TRDizin (32)
2026
20261. Evaluation of Long-Term Outcomes of Crohn’s Disease Complicated by Intra-Abdominal Abscess: A Retrospective International Cohort Study
Bacsur P., Nemeczek S., Filip R., Fousekis F., Mpakogiannis K., Kagramanova A., et al.
Journal of Clinical Medicine , vol.15, no.7, 2026 (SCI-Expanded, Scopus)
2026
20262. Rate and predictors of successful antitumor necrosis factor deescalation after dose intensification in inflammatory bowel disease patients: a real-world Greek-Turkish collaborative study
Viazis N., TÖRÜNER M., Papastergiou V., Mousourakis K., Christidou A., Tzouvala M., et al.
European journal of gastroenterology & hepatology , vol.38, no.1, pp.36-41, 2026 (SCI-Expanded, Scopus)
2026
20263. Clinical Impact of Cytomegalovirus Infection in Patients with Inflammatory Bowel Disease
Dursun B., GÜMÜŞSOY M., TÖRÜNER M.
Turkish Journal of Gastroenterology , vol.37, no.3, pp.373-379, 2026 (SCI-Expanded, Scopus, TRDizin)
2026
20264. Ustekinumab-induced Henoch-Schönlein purpura in Crohn's disease: a case report and literature review.
Toruner M. D., Guvenir T., Yilmaz V., Er R. E., Toruner M.
Intestinal research , vol.24, no.1, pp.177-181, 2026 (ESCI, Scopus)
2025
20255. Comparison of Azathioprine-Induced Pancreatitis and Gastrointestinal Intolerance in IBD: Role of Demographics, Clinical Variables, and HLA DQA1/DRB1 Alleles
EŞKAZAN T., Bakkaloglu O. K., TÖRÜNER M., KANİ H. T., Cavus B., YILMAZ V., et al.
Journal of Clinical Medicine , vol.14, no.23, 2025 (SCI-Expanded, Scopus)
2025
20256. Disease Monitoring in Inflammatory Bowel Disease Daily Clinical Practice and Impact on Treatment Decision Making: Real World Evidence From the Inflammatory Bowel Disease-PODCAST Study
Dignass A., Magro F., D’Amico F., Bamias G., Caprioli F. A., Franchimont D., et al.
United European Gastroenterology Journal , vol.13, no.10, pp.1984-1998, 2025 (SCI-Expanded, Scopus)
2025
20257. Novel DAG-Lactone-Based Vav1 Inhibitors Show Anti-proliferative Activity in Pancreatic Cancer Models.
Bellomo A., Toruner M., Elhalem E., Peach M. L., Gandolfi Donadío L., Giordano L., et al.
ChemMedChem , vol.20, no.23, 2025 (SCI-Expanded, Scopus)
2025
20258. Nuclear VAV1 increases GLI1-dependent transcription in pancreatic cancer cells.
Tader B. R., Almada L. L., Toruner M., LaRue-Nolan K. C., Marks D. L., Sigafoos A. N., et al.
The Journal of biological chemistry , vol.302, no.1, pp.110988, 2025 (SCI-Expanded, Scopus)
2025
20259. Paracrine regulation of pancreatic cancer cell response to chemotherapy by GLI2-collagen I signaling.
Vera R. E., Fernandez-Barrena M. G., Falero J. M., Kwon J. Y., Garza R. A., Sigafoos A. N., et al.
The Journal of biological chemistry , vol.301, no.7, pp.110311, 2025 (SCI-Expanded, Scopus)
2025
202510. Efficacy and safety of infliximab in patients with autoimmune hepatitis
Efe C., Lytvyak E., EŞKAZAN T., Liberal R., Androutsakos T., Gökçe D., et al.
Hepatology , vol.81, no.6, pp.1660-1670, 2025 (SCI-Expanded, Scopus)
2025
202511. Comparison of vedolizumab and ustekinumab treatment persistence in anti-TNF experienced perianal Crohn's Disease patients: A Single Center Experience
Eroglu Z., Acehan M. F., Koc O., Yilmaz V., Toruner M.
JOURNAL OF CROHNS & COLITIS , vol.19, 2025 (SCI-Expanded, Scopus)
2025
202512. Upadacitinib as a Rescue Therapy in Patients with Steroid- and Infliximab-Refractory Acute Severe Ulcerative Colitis: Real-Life Multicentre Results
Gulsen N. U., Bakkaloglu O. K., Kav T., KANİ H. T., Akpinar A., Akincioglu P., et al.
JOURNAL OF CROHNS & COLITIS
, vol.19, 2025 (SCI-Expanded, Scopus)
2025
202513. Enhancing Inflammatory Bowel Disease care: The role of mobile applications in disease management
Telli P., Cavus B., Ormeci A. c., Kalkan I. H., Karakan T., Arhan M., et al.
JOURNAL OF CROHNS & COLITIS
, vol.19, 2025 (SCI-Expanded, Scopus)
2025
202514. Comaparison of Effectiveness and Perisitence Anti-TNF drugs on Perianal Fistulizing Crohn's Disease: A Single Tertiary IBD Referral Center Experience
Koc O., Acehan M. F., Yilmaz V., Guvenir S. T., Toruner M.
JOURNAL OF CROHNS & COLITIS , vol.19, 2025 (SCI-Expanded, Scopus)
2025
202515. Evaluation of patient-reported outcome measures (PROMs) of IBD patients who completed upadacitinib induction period
Prof T. K., Unal N., Bakkaloglu O. K., Kani T., Akpinar A., Akincioglu P., et al.
JOURNAL OF CROHNS & COLITIS , vol.19, 2025 (SCI-Expanded, Scopus)
2025
202516. Delayed Diagnosis in Inflammatory Bowel Disease in Turkish Population
Acehan M. F., Yilmaz V., Koc O., Guvenir S. T., Er R. E., Soykan A., et al.
JOURNAL OF CROHNS & COLITIS , vol.19, 2025 (SCI-Expanded, Scopus)
2025
202517. Comparison of AZA-Related Pancreatitis and AZA-Related GI Intolerance Based on Demographic Factors, Clinical Variables and HLA DQA1/DRB1 Alleles
Eskazan T., Bakkaloglu O. K., Toruner M., KANİ H. T., Cavus B., Yilmaz V., et al.
JOURNAL OF CROHNS & COLITIS
, vol.19, 2025 (SCI-Expanded, Scopus)
2025
202518. The Effect of Extraintestinal Manifestations Presence on Treatment Persistence in IBD Treatment
Koc O., Eroglu Z., Yilmaz V., Acehan M. F., Guvenir S. T., Toruner M.
JOURNAL OF CROHNS & COLITIS , vol.19, 2025 (SCI-Expanded, Scopus)
2024
202419. Histological and clinical disease progression in patients with metabolic dysfunction-associated steatotic liver disease using paired liver biopsy
Ekelik M., Gokce D. T., Gumussoy M., KİREMİTCİ S., Bodakci E., Yilmaz V., et al.
JOURNAL OF HEPATOLOGY , 2024 (SCI-Expanded, Scopus)
2024
202420. DISEASE PROGRESSION IN PATIENTS WITH METABOLIC DYSFUNCTIONASSOCIATED STEATOTIC LIVER DISEASE USING PAIRED LIVER BIOPSY
Turan D., Ekelik M. M., Gumussoy M., Kiremitci S., Bodakci E., Yilmaz V., et al.
GASTROENTEROLOGY , vol.166, no.5, pp.1642, 2024 (SCI-Expanded, Scopus)
2024
202421. Comparison of infliximab and adalimumab therapies Persistence in patients with Ulcerative Colitis: Results from a Single Tertiary Turkish IBD Center Cohort
Eroglu Z., Yilmaz V., Guvenir T., Er R. E., Toruner M.
JOURNAL OF CROHNS & COLITIS , vol.18, 2024 (SCI-Expanded, Scopus)
2024
202422. Efficacy and Drug Adherence Rates of Anti TNF Drugs in patients with Crohn's Disease: A Single Tertiary IBD Center Cohort
Eroglu Z., Yilmaz V., Guvenir T., Er R. E., Toruner M.
JOURNAL OF CROHNS & COLITIS , vol.18, 2024 (SCI-Expanded, Scopus)
2024
202423. Epidemiological Characteristics of Inflammatory Bowel Diseases in The Last Decade: Multi-Center Turkiye Data
Akyuz F., Agargun B. F., Atug O., Eskazan T., Yuksel I., Kochan K., et al.
JOURNAL OF CROHNS & COLITIS , vol.18, 2024 (SCI-Expanded, Scopus)
2023
202324. SUFU promotes GLI activity in a Hedgehog-independent manner in pancreatic cancer.
Paradise B. D., Gainullin V. G., Almada L. L., Sigafoos A. N., Sen S., Vera R. E., et al.
The Biochemical journal , vol.480, no.15, pp.1199-1216, 2023 (SCI-Expanded, Scopus)
2023
202325. The Abdominal Ultrasonography Results of Cappadocia Cohort Study of Turkey Reveals High Prevalence of Fatty Liver
Sezgin O., AKPINAR H., Özer B., TÖRÜNER M., Bal K., Bor S.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.6, pp.652-664, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202326. GLI1, a novel target of the ER stress regulator p97/VCP, promotes ATF6f-mediated activation of XBP1.
Almada L. L., Barroso K., Sen S., Toruner M., Sigafoos A. N., Raja Arul G. L., et al.
Biochimica et biophysica acta. Gene regulatory mechanisms , vol.1866, no.2, pp.194924, 2023 (SCI-Expanded, Scopus)
2023
202327. Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta
Kalkan Ç., Yılmaz Y., Erdoğan B. D., SAVAŞ B., Yurdcu E., Çalışkan A., et al.
Journal of Viral Hepatitis , vol.30, no.5, pp.406-416, 2023 (SCI-Expanded, Scopus)
2023
202328. Epigenetics of Inflammatory Bowel Diseases
TÖRÜNER M., Ünal N. G.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.34, no.5, pp.437-448, 2023 (SCI-Expanded, Scopus, TRDizin)
2023
202329. Concomitant azathioprine treatment effects vedolizumab treatment persistence in Crohn's Disease but not in Ulcerative Colitis
Toruner M., Guvenir T., Er R. E., SOYKAN A. İ.
JOURNAL OF CROHNS & COLITIS , vol.17, pp.531-532, 2023 (SCI-Expanded, Scopus)
2023
202330. European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation.
Torres J., Chaparro M., Julsgaard M., Katsanos K., Zelinkova Z., Agrawal M., et al.
Journal of Crohn's & colitis , vol.17, pp.1-27, 2023 (SCI-Expanded, Scopus)
2023
202331. Management of iron-deficiency anemia following acute gastrointestinal hemorrhage: A narrative analysis and review.
Lanas A., Andrews J. M., Lau J., Toruner M., Bromley S. E., Gralnek I. M.
Journal of gastroenterology and hepatology , vol.38, no.1, pp.23-33, 2023 (SCI-Expanded, Scopus)
2022
202232. Perception of COVID-19 Pandemic Among IBD Clinicians and IBD Surgeons in Black Sea Region: A Cross-Sectional Questionnaire Study.
Celasin H., Törüner M., Aghayeva S., Bayramov N., Vardanyan A., Nanaeva B., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.33, pp.1004-1011, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202233. The Impact of Inflammatory Bowel Diseases and Related Medications on COVID-19 Severity and Outcome: A Tertiary Referral Center Experience from Turkey.
Er R. E., Duman S., Bodakçı E., Yarcı B., Soykan A. İ., Törüner M.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.33, no.12, pp.1025-1032, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202234. Culture media composition influences patient-derived organoids ability to predict therapeutic response in gastrointestinal cancers.
Hogenson T. L., Xie H., Phillips W. J., Toruner M. D., Li J. J., Horn I. P., et al.
JCI insight , vol.7, 2022 (SCI-Expanded, Scopus)
2022
202235. Evaluation of periodontal status and cytokine levels in saliva and gingival crevicular fluid of patients with inflammatory bowel diseases
Enver A., Özmeriç Kurtuluş N., İşler S. Ç., Törüner M., Fidan Ç., Demirci G., et al.
JOURNAL OF PERIODONTOLOGY , vol.93, no.11, pp.1649-1660, 2022 (SCI-Expanded, Scopus)
2022
202236. Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility
Savarino E., Zingone F., Barberio B., Marasco G., AKYÜZ F., AKPINAR H., et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL , vol.10, no.6, pp.556-584, 2022 (SCI-Expanded, Scopus)
2022
202237. Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn's Disease in Routine Clinical Practice in Turkey
TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., Senturk O., Akyuz F., Cekic C., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.33, no.5, pp.406-413, 2022 (SCI-Expanded, Scopus, TRDizin)
2021
202138. Assessment of Imaging Features of Crohn's Disease with MR Enterography
Onay M., Erden A., Binboga A. B., Altay C. M., Törüner M.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.32, no.8, pp.631-639, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202139. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.
Kucharzik T., Ellul P., Greuter T., Rahier J. F., Verstockt B., Abreu C., et al.
Journal of Crohn's & colitis
, vol.15, no.6, pp.879-913, 2021 (SCI-Expanded, Scopus)
2021
202140. Natural History of Cirrhosis: Changing Trends in Etiology Over the Years
İDİLMAN R., Aydogan M., Oruncu M. B., Kartal A., ELHAN A. H., Ellik Z., et al.
DIGESTIVE DISEASES , vol.39, no.4, pp.358-365, 2021 (SCI-Expanded, Scopus)
2021
202141. Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic
TÖRÜNER M., Kalkan I. H., Akyuz F., Tezel A., ÇELİK A. F.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.32, no.6, pp.488-492, 2021 (SCI-Expanded, Scopus)
2020
202042. New Aspects of the Epigenetics of Pancreatic Carcinogenesis.
Toruner M., Fernandez-Zapico M. E., Pin C. L.
Epigenomes
, vol.4, no.3, 2020 (ESCI)
2020
202043. Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study
Yamamoto-Furusho J. K., Al Harbi O., Armuzzi A., Chan W., de Leon E. P., Qian J., et al.
DIGESTIVE AND LIVER DISEASE
, vol.52, no.8, pp.869-877, 2020 (SCI-Expanded, Scopus)
2019
201944. Population-based assessment of gastrointestinal symptoms and diseases: Cappadocia Cohort, Turkey
SEZGİN O., AKARSU M., Ozer B., TÖRÜNER M., BAL K., TÖRÜNER M.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.30, no.12, pp.1009-1022, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201945. 2019 Expert opinion on biological treatment use in inflammatory bowel disease management
TÖRÜNER M., AKARSU M., Akyuz F., Dagli U., Hamzaoglu H. O., Tezel A., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.30, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201946. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
Sands B. E., Peyrin-Biroulet L., Loftus E. V., Danese S., Colombel J., TÖRÜNER M., et al.
NEW ENGLAND JOURNAL OF MEDICINE , vol.381, no.13, pp.1215-1226, 2019 (SCI-Expanded, Scopus)
2019
201947. Barriers to prescribing anti-TNF therapy in inflammatory bowel disease (IBD) across newly industrialised emerging market countries: an analysis of the 'EXPLORE' study
Ye B. D., Furusho J. K. Y., Khan M. R. Q., Fadeeva O., Demuth D., Qian J., et al.
JOURNAL OF CROHNS & COLITIS , vol.13, 2019 (SCI-Expanded, Scopus)
2019
201948. The influence of disease type and activity to sexual life and health quality in inflammatory bowel disease
Bulut E. A., TÖRÜNER M.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.30, no.1, pp.33-39, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201949. Backwash ileitis in ulcerative colitis: Are there MR enterographic features that distinguish it from Crohn disease?
Erden A., KURU ÖZ D., GÜRSOY ÇORUH A., Erden I., Ates F. S. O., TÖRÜNER M.
EUROPEAN JOURNAL OF RADIOLOGY , vol.110, pp.212-218, 2019 (SCI-Expanded, Scopus)
2018
201850. COST-EFFECTIVENESS ANALYSIS OF USTEKINUMAB VERSUS ADALIMUMAB, INFLIXIMAB AND VEDOLIZUMAB FOR THE TREATMENT OF PATIENTS WITH MODERATELY TO SEVERE ACTIVE CROHN'S DISEASE FOR TURKEY
Arhan M., Tezel H. A., TÖRÜNER M., Bilaloglu B., Koral S., Ozer E.
VALUE IN HEALTH
, vol.21, 2018 (SCI-Expanded, SSCI, Scopus)
2018
201851. A rare cause of small bowel obstruction
PEKER E., Erden A., Erden I., TÖRÜNER M.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.29, no.2, pp.237-238, 2018 (SCI-Expanded, Scopus, TRDizin)
2017
201752. MR Enterography in Crohn's disease complicated with enteroenteric fistula
Erden A., ÜNAL S., Akkaya H. E., Onay M., TÖRÜNER M., Gencturk Z. B., et al.
EUROPEAN JOURNAL OF RADIOLOGY , vol.94, pp.101-106, 2017 (SCI-Expanded, Scopus)
2017
201753. Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: iron deficiency anemia working group consensus report
AKARSU M., Cetiner M., Keshav S., Ormeci N., TÖRÜNER M.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.28, no.2, pp.81-87, 2017 (SCI-Expanded, Scopus, TRDizin)
2017
201754. Anti-TNF treatments in Crohn's disease and improvement in work productivity and quality of life: an observational study from Turkey
TÖRÜNER M., Basaranoglu M., Atug O., Sentruk O., Akyuz F., Unsal B., et al.
JOURNAL OF CROHNS & COLITIS , vol.11, 2017 (SCI-Expanded, Scopus)
2016
201655. Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease
Ustun Y., Kilincalp S., Coban S., Coskun Y., YÜKSEL İ., ONGUN A., et al.
MEDICAL SCIENCE MONITOR
, vol.22, pp.3943-3950, 2016 (SCI-Expanded, Scopus)
2016
201656. Anti-INF-α agents and serum lipids in inflammatory bowel diseases
Kalkan C., Karakaya F., TÖRÜNER M., Cetinkaya H., Soykan I.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , no.4, 2016 (SCI-Expanded, Scopus)
2016
201657. Association between single nucleotide polymorphisms in prospective genes and susceptibility to ankylosing spondylitis and inflammatory bowel disease in a single centre in Turkey
KÜÇÜKŞAHİN O., ATEŞ A., Turkcapar N., TÖRÜNER M., Turgay M., Duman T., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , no.4, pp.317-324, 2016 (SCI-Expanded, Scopus, TRDizin)
2015
201558. Association of Matrix Metalloproteinases and Their Tissue Inhibitor With Disease Activity and Development in Spondyloarthropathy and Inflammatory Bowel Disease
Elmas D., ŞAHİN A., KÜÇÜKŞAHİN O., Turkcapar N., TÖRÜNER M., Cetinkaya H., et al.
ARCHIVES OF RHEUMATOLOGY
, vol.30, no.3, pp.191-197, 2015 (SCI-Expanded, Scopus, TRDizin)
2015
201559. Health Quality and Sexual Dysfunction in Turkish IBD Patients
TÖRÜNER M., Ates E., Kalkan C., Karakaya F., Cetinkaya H., Soykan I.
JOURNAL OF CROHNS & COLITIS , vol.9, 2015 (SCI-Expanded, Scopus)
2014
201460. Autoimmune disease, tumor necrosis factor inhibitors and acute leukemia: possible associations in two patients?
Ozen M., Keskin O., TOPÇUOĞLU P., Ozturk B., Ozgul S., Ilgen U., et al.
LEUKEMIA & LYMPHOMA , vol.55, no.7, pp.1697-1698, 2014 (SCI-Expanded, Scopus)
2014
201461. Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines
Gomollon F., Chowers Y., Danese S., Dignass A., Nielsen O. H., Lakatos P. L., et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.39, no.7, pp.743-744, 2014 (SCI-Expanded, Scopus)
2014
201462. Prevalence of iron deficiency anemia and iron deficiency in a single center Turkish IBD cohort
TÖRÜNER M., Kalkan C., Keskin O., Cetinkaya H., Soykan I.
JOURNAL OF CROHNS & COLITIS
, vol.8, 2014 (SCI-Expanded, Scopus)
2014
201463. ERAP-1 gene polymorphisms in Turkish patients with inflammatory bowel diseases and anyklosing spondylitis
KÜÇÜKŞAHİN O., Turkcapar N., Ates A., TÖRÜNER M., Duman T., Cetinkaya H., et al.
JOURNAL OF CROHNS & COLITIS
, vol.8, 2014 (SCI-Expanded, Scopus)
2014
201464. The Role of Anti-Cd74 Antibody in The Development of Spondyloarthropathy in Ankylosing Spondylitis and Inflammatory Bowel Disease and Disease Activity
Yurumez S., KÜÇÜKŞAHİN O., Turgay M., ATEŞ A., TÖRÜNER M., Cetinkaya H., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.32, no.4, 2014 (SCI-Expanded, Scopus)
2014
201465. The Frequency of Spondyloarthropathy in Inflammatory Bowel Diseases
KÜÇÜKŞAHİN O., ATEŞ A., TÖRÜNER M., Turkcapar N., ŞAHİN A., Turgay M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.32, no.4, 2014 (SCI-Expanded, Scopus)
2014
201466. Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I)
Sebastian S., Hernandez V., Myrelid P., Kariv R., Tsianos E., TÖRÜNER M., et al.
JOURNAL OF CROHNS & COLITIS
, vol.8, no.1, pp.5-18, 2014 (SCI-Expanded, Scopus)
2014
201467. Ülseratif kolitli hastalarda displazi varlığı ve displastik mukozada p53 ve Ki 67 ekspresyonu
BEKTAŞ M., SAVAŞ B., ÇETİNKAYA H., TÖRÜNER M., ENSARİ A., DOĞANAY B., et al.
Akademik Gastroenteroloji Dergisi , vol.13, no.2, pp.41-46, 2014 (TRDizin)
2013
201368. The management of iron deficiency in inflammatory bowel disease - an online tool developed by the RAND/UCLA appropriateness method
Reinisch W., Chowers Y., Danese S., Dignass A., Gomollon F., Nielsen O. H., et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
, vol.38, no.9, pp.1109-1118, 2013 (SCI-Expanded, Scopus)
2013
201369. The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
Feagan B. G., Sandborn W. J., D'Haens G., Pola S., McDonald J. W., Rutgeerts P., et al.
Gastroenterology
, vol.145, no.1, 2013 (SCI-Expanded, Scopus)
2013
201370. Adsorptive Leukocytapheresis in Inflammatory Bowel Diseases: Our Preliminary Results are Encouraging
TÖRÜNER M., TOPRAK S. K., Mizrak K., Yildirim Y., Bay M., Ayyildiz E., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.2, pp.219-220, 2013 (SCI-Expanded, Scopus, TRDizin)
2012
201271. Effects of Helicobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells
Bektaş M., Saraç N., Çetinkaya H., TÖRÜNER M., ERDEMLİ E., Keskin O., et al.
Annals of Gastroenterology , vol.25, no.2, pp.123-127, 2012 (Scopus)
2012
201272. Can azathioprine/6-mercaptopurine treatment be withdrawn in patients with response in ulcerative colitis: What is the most appropriate time for this?
Kabacam G., TÖRÜNER M.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.23, pp.17-20, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
201273. How long should we treat patients with azathioprine/6-mercaptopurine before deciding that it is refractory to immunomodulatory treatment?
Kabacam G., TÖRÜNER M.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.23, pp.13-16, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
201274. Effects of Helicobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells.
Bektaş M., Saraç N., Cetinkaya H., Törüner M., Erdemli E., Keskin O., et al.
Annals of gastroenterology , vol.25, no.2, pp.123-127, 2012 (Scopus)
2011
201175. The Effect of Endogenous Hypergastrinemia on Lower Esophageal Sphincter Pressure and Esophageal Motility
Yakut M., Kabacam G., Bektas M., Cetinkaya H., TÖRÜNER M., Soykan I.
HEPATO-GASTROENTEROLOGY
, vol.58, no.112, pp.1989-1992, 2011 (SCI-Expanded, Scopus)
2011
201176. The effect of age and Helicobacter pylori infection on gastric epithelial cell kinetics
Coban S., Soykan I., TÖRÜNER M., AKBULUT H., Atli T., ENSARİ A.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
, vol.35, no.10, pp.661-665, 2011 (SCI-Expanded, Scopus)
2011
201177. Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D
Seven G., Karatayli S. C., KÖSE S. K., Yakut M., Kabacam G., TÖRÜNER M., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.22, no.3, pp.305-314, 2011 (SCI-Expanded, Scopus, TRDizin)
2010
201078. Is the prevalence of intestinal metaplasia at the squamocolumnar junction different in patients with progressive sytemic sclerosis?
VARDAR R., Vardar E., TÖRÜNER M.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.21, no.3, pp.251-256, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
201079. The Characteristics and Clinical Outcome of Drug-induced Liver Injury A Single-center Experience
İDİLMAN R., Bektas M., Cinar K., TÖRÜNER M., Cerit E. T., DOĞANAY ERDOĞAN B., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY , vol.44, no.6, 2010 (SCI-Expanded, Scopus)
2010
201080. The Impact of the Speed of Food Intake on Intraesophageal Reflux Events in Obese Female Patients
Vardar R., Valytova E., Belen E., Bayrakci B., TÖRÜNER M.
GASTROENTEROLOGY , vol.138, no.5, 2010 (SCI-Expanded, Scopus)
2010
201081. The Feasibility of 24 Hour Ambulatory Multichannel Intraluminal Impedance in Patients With Progressive Systemic Sclerosis
Bayrakci B., Yargucu F., Vardar R., Oksel F., TÖRÜNER M.
GASTROENTEROLOGY , vol.138, no.5, 2010 (SCI-Expanded, Scopus)
2010
201082. Proteasome Inhibitor Bortezomib Decreases Mouse Colitis-Associated Tumor Formation
TÖRÜNER M., Nalluri M. K., Han J. J., Sanderson S., Inderhaug C., Callagy G., et al.
GASTROENTEROLOGY , vol.138, no.5, 2010 (SCI-Expanded, Scopus)
2010
201083. Sexual Intercourse Does Not Increase the Reflux on Patients With Gastroesophageal Reflux Disease
TÖRÜNER M., Vardar R., Valytova E., Belen E.
GASTROENTEROLOGY , vol.138, no.5, 2010 (SCI-Expanded, Scopus)
2010
201084. What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?
Kabacam G., TÖRÜNER M.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.21, no.1, pp.107-112, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
201085. Prevalence of gastroesophageal reflux disease in patients with asthma and chronic obstructive pulmonary disease
TÖRÜNER M., KİTAPÇIOĞLU G., Solak Z. A., Ertilav M., ERDİNÇ M.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , vol.25, no.2, pp.309-313, 2010 (SCI-Expanded, Scopus)
2010
201086. Cost Analysis in Ankara University School of Medicine Hospitals
Esatoğlu A. E., Ağırbaş İ., Doğanay Payziner P., Akbulut Y., Göktaş B., Özatkan Y., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası
, vol.63, no.1, pp.17-27, 2010 (TRDizin)
2010
201087. Ankara Üniversitesi Tıp Fakültesi Hastaneleri'nde Maliyet Analizi
ESATOĞLU A. E., AĞIRBAŞ İ., Payzıner P. D., AKBULUT Y., GÖKTAŞ B., Ozatkan Y., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.63, no.1, pp.17-27, 2010 (TRDizin)
2010
201088. The frequency of sexual-physical abuse history in irritabl bowel syndrome patients and diagnostic relation with major depressive disorder history
EKER M. Ç., KASAP E., ELBİ H., TÖRÜNER M.
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY , vol.11, no.2, pp.120-126, 2010 (SCI-Expanded, Scopus, TRDizin)
2009
200989. Esophageal intramural pseudodiverticulosis associated with achalasia: an unusual endoscopic appearance
TURAN İ., Ozen E., TÖRÜNER M., Ozutemiz O.
ENDOSCOPY
, vol.41, 2009 (SCI-Expanded, Scopus)
2009
200990. Validity and Reliability of a Turkish Version of the Fecal Incontinence Quality of Life Scale
Dedeli O., Fadiloglu C., TÖRÜNER M.
JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING , vol.36, no.5, pp.532-538, 2009 (SCI-Expanded, SSCI, Scopus)
2009
200991. The evaluation of VEGF and endostatin expressions and serum levels in ulcerative colitis
Savas B., Kahramanoglu E., Ustun Y., Cetinkaya H., TÖRÜNER M., Ozden A., et al.
VIRCHOWS ARCHIV , vol.455, pp.125-126, 2009 (SCI-Expanded, Scopus)
2009
200992. The additive effect of ethanol and extract of cigarette smoke on rabbit esophagus epithelium
TÖRÜNER M., Capanoglu D.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
, vol.24, no.2, pp.316-321, 2009 (SCI-Expanded, Scopus)
2009
200993. Eating Disorder Symptoms Improved by Antireflux Surgery: A Case Report with a Six-Year Follow Up
Eraslan D., Ozturk O., TÖRÜNER M.
ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES , vol.46, no.3, pp.231-235, 2009 (SCI-Expanded, SSCI, Scopus)
2008
200894. Low prevalence of erosive esophagitis and Barrett esophagus in a tertiary referral center in Turkey
Bayrakci B., Kasap E., Kitapcioglu G., TÖRÜNER M.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.19, no.3, pp.145-151, 2008 (SCI-Expanded, Scopus, TRDizin)
2008
200895. Effects of polymorphism in G2677T/A triallelic region of MDR1 gene in Turkish patients with inflammatory bowel disease
Sapmaz A., Karatayli S. C. O., Dagli U., Kilic Z. M. Y., TÖRÜNER M., Celik Y., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.19, no.3, pp.168-173, 2008 (SCI-Expanded, Scopus, TRDizin)
2008
200896. Endoscopic findings of gastroesophageal reflux disease in Turkey: Multicenter prospective study (Gorhen)
TÖRÜNER M., Vardar R., Vardar E., Takamz S., Mungan Z. A.
GASTROENTEROLOGY , vol.134, no.4, 2008 (SCI-Expanded, Scopus)
2008
200897. Risk factors for opportunistic infections in patients with inflammatory bowel disease
TÖRÜNER M., Loftus E. V., Harmsen W. S., Zinsmeister A. R., Orenstein R., Sandborn W. J., et al.
GASTROENTEROLOGY , vol.134, no.4, pp.929-936, 2008 (SCI-Expanded, Scopus)
2008
200898. PREVALANCE OF FECAL INCONTINENCE AND ITS EFFECT ON QUALITY OF LIFE IN ELDERLY INDIVIDUALS LIVING IN NURSING HOMES IN THE CITY OF IZMIR
Dedeli O., Fadiloglu C., TURAN İ., TÖRÜNER M.
TURK GERIATRI DERGISI-TURKISH JOURNAL OF GERIATRICS , vol.11, no.1, pp.33-41, 2008 (SCI-Expanded, Scopus, TRDizin)
2007
200799. Prevalence patterns of gastric cancers in Turkey: Model of a developing country with high occurrence of Helicobacter pylori
TÖRÜNER M., Vardar R., Ormeci N., Memik F., Suleymanlar I., Oguz D., et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
, vol.22, no.12, pp.2242-2245, 2007 (SCI-Expanded, Scopus)
2007
2007100. The acute effect of oral ethanol intake on gastric myoelectrical activity in healthy volunteers
Kobak A. C., TÖRÜNER M.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.18, no.4, pp.221-224, 2007 (SCI-Expanded, Scopus, TRDizin)
2007
2007101. Aspirin and gastrointestinal toxicity
TÖRÜNER M.
ANATOLIAN JOURNAL OF CARDIOLOGY
, vol.7, pp.27-30, 2007 (SCI-Expanded, Scopus, TRDizin)
2007
2007102. Association of heartburn during pregnancy with the risk of gastroesophageal reflux disease
TÖRÜNER M., Kitapcioglu G., Dettmar P., Baxter T.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
, vol.5, no.9, pp.1035-1039, 2007 (SCI-Expanded, Scopus)
2007
2007103. The effect of laparoscopic Nissen fundoplication on laryngeal findings and voice quality
Ogut F., Ersin S., Engin E. Z., Kirazli T., Midilli R., Unsal G., et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES , vol.21, no.4, pp.549-554, 2007 (SCI-Expanded, Scopus)
2007
2007104. Does an acute increase of intraabdominal pressure effect esophageal sphincter pressure?
Yimaz N., Musoglu A., ÖNER K. S., TÖRÜNER M.
HEPATO-GASTROENTEROLOGY , vol.54, no.74, pp.434-437, 2007 (SCI-Expanded, Scopus)
2007
2007105. Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community
Kitapcioglu G., MANDIRACIOĞLU A., BOR C., TÖRÜNER M.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.18, no.1, pp.14-19, 2007 (SCI-Expanded, Scopus, TRDizin)
2007
2007106. Fucidic acid use in metronidazole nonresponders with Clostridium difficile infection
Bektas M., Toeruener M., Cetinkaya H., Soykan I., Oezden A.
DIGESTION
, vol.75, no.4, pp.177-178, 2007 (SCI-Expanded, Scopus)
2007
2007107. Use of case-based exams as an instructional teaching tool to teach clinical reasoning
Durak H. I., ÇALIŞKAN S. A., TÖRÜNER M., Van der Vleuten C.
MEDICAL TEACHER
, vol.29, no.6, 2007 (SCI-Expanded, Scopus)
2007
2007108. Methodology and possibilities of manometry in the diagnosis of esophageal disease
Bordin D. S., TÖRÜNER M., Vasilyev Y. V.
TERAPEVTICHESKII ARKHIV , vol.79, no.4, pp.63-71, 2007 (SCI-Expanded, Scopus)
2006
2006109. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease
Celik Y., Dagli U., Kilic M., TÖRÜNER M., Ozen S., Ozkan M. M., et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , vol.41, no.5, pp.559-565, 2006 (SCI-Expanded, Scopus)
2006
2006110. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease
Turkcapar N., TÖRÜNER M., Soykan I., Aydintug O., Cetinkaya H., Duzgun N., et al.
RHEUMATOLOGY INTERNATIONAL , vol.26, no.7, pp.663-668, 2006 (SCI-Expanded, Scopus)
2006
2006111. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease
Ozen S. C., Dagli U., Kilic M. Y., TÖRÜNER M., Celik Y., Ozkan M., et al.
JOURNAL OF GASTROENTEROLOGY
, vol.41, no.4, pp.304-310, 2006 (SCI-Expanded, Scopus)
2006
2006112. Antianoikis effect of nuclear factor-kappa B through up-regulated expression of osteoprotegerin, BCL-2, and IAP-1
TÖRÜNER M., Fernandez-Zapico M., Sha J., Pham L., Urrutia R., Egan L.
JOURNAL OF BIOLOGICAL CHEMISTRY
, vol.281, no.13, pp.8686-8696, 2006 (SCI-Expanded, Scopus)
2006
2006113. NF-kappa B signaling - Pros and cons of altering NF-kappa B as a therapeutic approach
Egan L. J., TÖRÜNER M.
INFLAMMATORY BOWEL DISEASE: GENETICS, BARRIER FUNCTION, IMMUNOLOGIC MECHANISMS, AND MICROBIAL PATHWAYS
, vol.1072, pp.114-122, 2006 (SCI-Expanded, Scopus)
2005
2005114. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacter pylori eradication
Duman D., TÖRÜNER M., Ozutemiz O., Sahin T., Oguz D., Isitan F., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, vol.17, no.12, pp.1357-1361, 2005 (SCI-Expanded, Scopus)
2005
2005115. Preswallowing dystonia
Ertekin C., Aydogdu I., Ozdemirkiran T., Secil Y., TÖRÜNER M.
DYSPHAGIA , vol.20, no.1, pp.15-18, 2005 (SCI-Expanded, Scopus)
2005
2005116. Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season
Onbasi K., Sin A., Doganavsargil B., Onder G., TÖRÜNER M., Sebik F.
CLINICAL AND EXPERIMENTAL ALLERGY , vol.35, no.11, pp.1423-1431, 2005 (SCI-Expanded, Scopus)
2005
2005117. Swallow-induced syncope in a patient with achalasia
TURAN İ., Ersoz G., TÖRÜNER M.
DYSPHAGIA
, vol.20, no.3, pp.238-240, 2005 (SCI-Expanded, Scopus)
2005
2005118. Lamivudine vs lamivudine and interferon combination treatment of HBeAg(-) chronic hepatitis B
Yurdaydin C., Bozkaya H., Cetinkaya H., Sahin T., Karaoguz D., TÖRÜNER M., et al.
Journal of Viral Hepatitis
, vol.12, no.3, pp.262-268, 2005 (SCI-Expanded, Scopus)
2005
2005119. Manometric assessment of esophageal motility in patients with primary Sjorgren's syndrome
Turk T., Pirildar T., Tunc E., TÖRÜNER M., Doganavsargil E.
RHEUMATOLOGY INTERNATIONAL , vol.25, no.4, pp.246-249, 2005 (SCI-Expanded, Scopus)
2005
2005120. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease
TÖRÜNER M., Harewood G., Loftus E., Sandborn W., Tremaine W., Faubion W., et al.
INFLAMMATORY BOWEL DISEASES
, vol.11, no.5, pp.428-434, 2005 (SCI-Expanded, Scopus)
2005
2005121. Gastroesophageal reflux disease in a low-income region in Turkey
TÖRÜNER M., Mandiracioglu A., Kitapcioglu G., Caymaz-Bor C., Gilbert R.
AMERICAN JOURNAL OF GASTROENTEROLOGY
, vol.100, no.4, pp.759-765, 2005 (SCI-Expanded, Scopus)
2004
2004122. Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease.
TÖRÜNER M., Erkan Ö., Soykan I., Bozdayi M., Çetinkaya H., Yurdaydin C., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.15, no.4, pp.250-2, 2004 (Scopus, TRDizin)
2004
2004123. Metalloprotease disintegrin-mediated ectodomain shedding of EGFR ligands promotes intestinal epithelial restitution
Myhre G., TÖRÜNER M., Abraham S., Egan L.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY , vol.287, no.6, 2004 (SCI-Expanded, Scopus)
2004
2004124. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.
TÖRÜNER M., Bektaş M., Çetinkaya H., Soykan I., Özden A.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , vol.15, no.4, pp.225-8, 2004 (Scopus, TRDizin)
2004
2004125. Barrett's esophagus: Prevalence and its relationship with dyspeptic symptoms
TÖRÜNER M., Soykan I., Ensari A., KUZU I., Yurdaydin C., Ozden A.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
, vol.19, no.5, pp.535-540, 2004 (SCI-Expanded, Scopus)
2004
2004126. Colorectal cancer surveillance in inflammatory bowel diseases
TÖRÜNER M.
Turkish Journal of Cancer
, vol.34, no.2, pp.55-59, 2004 (Scopus)
2004
2004127. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies
Idilman R., Arat M., Soydan E., TÖRÜNER M., Soykan I., Akbulut H., et al.
JOURNAL OF VIRAL HEPATITIS
, vol.11, no.2, pp.141-147, 2004 (SCI-Expanded, Scopus)
2004
2004128. Psychometric and methodological characteristics of a culturally adjusted gastroesophageal reflux disease questionnaire
Kitapcioglu G., Mandiracioglu A., TÖRÜNER M.
DISEASES OF THE ESOPHAGUS
, vol.17, no.3, pp.228-234, 2004 (SCI-Expanded, Scopus)
2003
2003129. Eosinophilic bronchitis as a cause of chronic cough
Ayik S., KAÇMAZ BAŞOĞLU Ö., Erdinc M., TÖRÜNER M., Veral A., Bilgen C.
RESPIRATORY MEDICINE , vol.97, no.6, pp.695-701, 2003 (SCI-Expanded, Scopus)
2003
2003130. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux
Bilgen C., Ogut F., Kesimli-Dinc H., Kirazli T., TÖRÜNER M.
JOURNAL OF LARYNGOLOGY AND OTOLOGY , vol.117, no.5, pp.386-390, 2003 (SCI-Expanded, Scopus)
2003
2003131. Effect of hypo- and hyperthyroidism on gastric myoelectrical activity
Gunsar F., Yilmaz S., TÖRÜNER M., Kumanlioglu K., Cetinkalp S., Kabalak T., et al.
DIGESTIVE DISEASES AND SCIENCES , vol.48, no.4, pp.706-712, 2003 (SCI-Expanded, Scopus)
2003
2003132. Reversal of iron deficiency anemia in a patient with gastric antral vascular ectasia treated with cyproheptadine
Soykan I., TÖRÜNER M., Idilman R., Ozden A.
JOURNAL OF CLINICAL GASTROENTEROLOGY , vol.36, no.2, pp.183-184, 2003 (SCI-Expanded, Scopus)
2002
2002133. Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance - Potential role of lamivudine
Bozkaya H., Yurdaydin C., TÖRÜNER M., Arat M., Bozdayi A., Erekul S., et al.
DIGESTIVE DISEASES AND SCIENCES
, vol.47, no.8, pp.1782-1785, 2002 (SCI-Expanded, Scopus)
2002
2002134. Is pain experienced during liver biopsy an important factor?
Soykan I., TÖRÜNER M., Sarioglu M., Idilman R.
JOURNAL OF CLINICAL GASTROENTEROLOGY , vol.35, no.1, pp.102-103, 2002 (SCI-Expanded, Scopus)
2002
2002135. Is fatigue of cholestasis mediated by altered central serotoninergic neurotransmission?
Celik T., Aslan N., Goren Z., GÜRDAL H., Degim T., TÖRÜNER M., et al.
JOURNAL OF HEPATOLOGY , vol.36, pp.29, 2002 (SCI-Expanded, Scopus)
2001
2001136. Repopulation of liver endothelial cells, but not hepatocytes, by allogeneic hematopoietic cell transplants.
Idilman R., Tukun A., Erdem E., Arat M., TÖRÜNER M., Soykan I., et al.
BLOOD , vol.98, no.11, 2001 (SCI-Expanded, Scopus)
2001
2001137. B-cell lymphoproliferative and plasma cell disorders in individuals with chronic hepatitis C.
Idilman R., Colantoni A., De Maria N., Alkan S., Nand S., Soykan I., et al.
HEPATOLOGY
, vol.34, no.4, 2001 (SCI-Expanded, Scopus)
2001
2001138. Is fatigue of cholestasis mediated by altered central serotoninergic neurotransmission?.
Yurdaydin C., Celik T., Goren Z., GÜRDAL H., Degim T., TÖRÜNER M., et al.
HEPATOLOGY , vol.34, no.4, 2001 (SCI-Expanded, Scopus)
2001
2001139. Gastroesophageal reflux disease in an urban population in Turkey: A model of a developing nation with high H. pylori prevalence
TÖRÜNER M., Mandiracioglu A., Kitapcioglu G., Caymaz-Bor C., Zeytinoglu H., Gilbert R.
GASTROENTEROLOGY , vol.120, no.5, 2001 (SCI-Expanded, Scopus)
1999
1999140. Is administration of n-3 fatty acids by mucosal enema protective against trinitrobenzene-induced colitis in rats?
Yuceyar H., Ozutemiz O., Huseyinov A., Saruc M., Alkanat M., TÖRÜNER M., et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS , vol.61, no.6, pp.339-345, 1999 (SCI-Expanded, Scopus)
1999
1999141. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat
Shah V., TÖRÜNER M., Haddad F., Cadelina G., Papapetropoulos A., Choo K., et al.
GASTROENTEROLOGY , vol.117, no.5, pp.1222-1228, 1999 (SCI-Expanded, Scopus)
1999
1999142. Bioactivation of nitroglycerin and vasomotor response to nitric oxide is impaired in cirrhotic rat livers.
Dudenhoefer A., TÖRÜNER M., Cadelina G., Groszmann R.
HEPATOLOGY , vol.30, no.4, 1999 (SCI-Expanded, Scopus)
1999
1999143. Mechanisms of basolateral Na+ transport in rabbit esophageal epithelial cells
Abdulnour-Nakhoul S., TÖRÜNER M., Imeryuz N., Orlando R.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY , vol.276, no.2, 1999 (SCI-Expanded, Scopus)
1999
1999144. Esophageal exposure to ethanol increases risk of acid damage in rabbit esophagus
TÖRÜNER M., Bor-Caymaz C., Tobey N., Abdulnour-Nakhoul S., Orlando R.
DIGESTIVE DISEASES AND SCIENCES , vol.44, no.2, pp.290-300, 1999 (SCI-Expanded, Scopus)
1998
1998145. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats
Gupta T., TÖRÜNER M., Chung M., Groszmann R.
HEPATOLOGY , vol.28, no.4, pp.926-931, 1998 (SCI-Expanded, Scopus)
1998
1998146. Role of nitric oxide
Gupta T., TÖRÜNER M., Groszmann R.
DIGESTION , vol.59, no.4, pp.413-415, 1998 (SCI-Expanded, Scopus)
1998
1998147. Impaired nitric oxide release in cirrhotic rat liver.
Haddad F., TÖRÜNER M., Shah V., Gupta T., Groszmann R.
GASTROENTEROLOGY , vol.114, no.4, 1998 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences
2024
20241. Age matters! Defining the diversity in upper gastrointestinal involvement in infammatory bowel disease
Kahraman H., Berber H., Jevtic J., Bol A., Davaji J., Özdemir S., et al.
36th European Congress of Pathology, Florence, Italy, 7 September - 11 October 2024, pp.1-546, (Summary Text)
2024
20242. DISEASE PROGRESSION IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE USING PAIRED LIVER BIOPSY
TURAN GÖKÇE D., Ekelik M. M., Gumussoy M., Kiremitci S., Bodakci E., Yilmaz V., et al.
Digestive Disease Week (DDW), Washington, Kiribati, 18 - 21 May 2024, vol.166, (Summary Text)
2022
20223. Enflamatuvar Barsak Hastalığı Tanılı Hastalarda Sitomegalovirüs Enfeksiyonlarının Değerlendirilmesi
İNAN M., SARICAOĞLU E. M., ÇINAR G., AKDEMİR İ., GÜLTEN E., ENSARİ A., et al.
10. Türkiye EKMUD Bilimsel Kongresi, 25 - 29 May 2022, (Summary Text)
2022
20224. Enflamatuar Barsak Hastalığı Tanılı Hastalarda Sitomegalovirüs Enfeksiyonlarının Değerlendirilmesi
İnan M., Sarıcaoğlu E. M., Çınar G., Akdemir Kalkan İ., Gülten E., Ensari A., et al.
10. Türkiye EKMUD Bilimsel Kongresi, Antalya, Turkey, 25 - 29 May 2022, pp.130, (Full Text)
2020
20205. Hermasky-Pudlak Syndrome: A Case Report
TAŞDELEN E., KAPLAN İ., TÖRÜNER M., ILGIN RUHİ H.
1. Bursa Uluslararası Katılımlı Genetik Günleri Dermatogenetik Sempozyumu, Turkey, 9 - 11 January 2020, (Summary Text)
2019
20196. Population Based Assesment of Gastrointestinal Symptoms and Diseases: Cappadocia Cohort, Turkey
SEZGİN O., Akpınar H., ÖZER B., TÖRÜNER M., BAL K., BOR S.
UEGW 2019, Barselona, 19 - 23 October 2019, (Summary Text)
2019
20197. Incidence and Indicators of Suboptimal Response to Tumor Necrosis Factor Antagonist Therapy in Inflammatory Bowel Disease in Newly Industrialized Countries: Results From the EXPLORE Study
Al Harbi O., Armuzzi A., Chan W., de Leon E. P., Qian J., Shapina M., et al.
Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), San-Antonio, Northern Mariana Islands, 25 - 30 October 2019, vol.114, (Summary Text)
2019
20198. Serum or urinary neopterin which is the best for evaluate disease activity in inflammatory bowel disease?
ÇETİNKAYA H., MELEKOĞLU ELLİK Z., KENARLI K., DUMAN S., EVREN E., KARAHAN Z. C., et al.
Proceedings of the World Congress of Gastroenterology, İstanbul, Turkey, 21 - 24 September 2019, vol.30, pp.810, (Summary Text)
2019
20199. EVIDENCE BASED RECOMMENDATIONS FOR THE MANAGEMENT OF ENTEROPATHIC ARTHRITIS: A RHEUMATOLOGY, GASTROENTEROLOGY COLLABORATIVE INITIATIVE
HATEMİ G., AKAR S., AKARSU M., ATAGÜNDÜZ M. P., BENGİ G., CAN G., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 12 - 15 June 2019, vol.78, pp.881, (Summary Text)
2018
201810. Surgical Rates for Crohn’xxs Disease: A monocentric Cross Section Study from Turkey
Bulat B., Köken e., Bilgiç C., AKYOL C., özel m., Kenarlı K., et al.
Falk Syposium No:213, 5 - 06 October 2018, (Summary Text)
2018
201811. Managing IBD in Rheumatic Disease
TÖRÜNER M.
Ninth International Immunology Summit, Czech Republic, 8 - 10 March 2018, (Full Text)
2018
201812. Managing IBD in Rheumatic Diseases
TÖRÜNER M.
Ninth International Immunology Summit, 8 - 10 March 2018
2017
201713. Cytomegalovirus Infection in Inflammatory Bowel Diseases in a Large Single Center Cohort
Murat T., Bengu M., Onur K.
Annual Meeting on Advances in Inflammatory Bowel Diseases (AIBD) - Multidisciplinary Approaches to IBD Patient-Centered Care, Florida, United States Of America, 9 - 11 November 2017, vol.113, (Summary Text)
2017
201714. İNFLAMATUVAR BARSAK HASTALIĞI’NDASITOMEGALOVIRÜS (CMV) ENFEKSIYONU SIKLIĞIRISK FAKTÖRLERI VE KLINIK SEYIR
MANTI B., TÖRÜNER M., KESKİN O.
34. Ulusal Gastroenteroloji Haftası, Turkey, 1 - 06 December 2017, (Summary Text)
2017
201715. Cytomegalovirus Infection in IBD: Single Center Experience
Manti B., Keskin O., TÖRÜNER M.
82nd Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), Florida, United States Of America, 13 - 18 October 2017, vol.112, (Summary Text)
2017
201716. Case Report: Post-Liver Transplant Crohn's Disease Refractory to Anti-tumor Necrosis Factor Agents
Yilmaz Y., Keskin O., TÖRÜNER M.
82nd Annual Scientific Meeting of the American-College-of-Gastroenterology (ACG), Florida, United States Of America, 13 - 18 October 2017, vol.112, (Summary Text)
2017
201717. Treatment Algorithms in Crohn’xxs disease in daily practice
TÖRÜNER M.
16th International Euroasian Congress of Gastroenterology and Surgery, 27 - 30 April 2017, (Full Text)
2017
201718. P401 Anti-TNF treatments in Crohn s disease and improvement in work productivity and quality of life: an observational study from Turkey
TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., ŞENTÜRK Ö., AKYÜZ F., ÜNSAL B., et al.
ECCO (EUROPEAN CROHNS AND COLITIS ORGANISATION), Barcelona, Spain, 15 - 18 February 2017, (Summary Text)
2017
201719. Anti-TNF treatments in Crohn’xxs disease and improvement in work productivity and quality of life: an observational study from Turkey
TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., ŞENTÜRK Ö., AKYÜZ F., ÜNSAL B., et al.
JOURNAL OF CROHNS COLITIS, 01 February 2017, vol.11, pp.281, (Summary Text)
2016
201620. Inflammatory Bowel Diseases
TÖRÜNER M.
FLORIDA INT UNIVERSITY, DEPT. SURGERY - GRAND ROUNDS, 18 November 2016, (Full Text)
2016
201621. Crohn hastalığına bağlı enteroenetrik fistüller MR enterografi kl n k laboratuar ve endoskopi bulgularının değerlendirilmesi
ünal s., AKKAYA H. E., onay m., ÇALIŞKAN KARTAL A., bıyıklı gençtürk z., TÖRÜNER M., et al.
37. Ulusal Radyoloji Kongresi, Turkey, 1 - 05 November 2016, (Full Text)
2016
201622. MR enterografi, klinik, laboratuvar ve endoskopik bulguların değerlendirilmesi
ÜNAL S., AKKAYA H. E., ONAY M., ÇALIŞKAN KARTAL A., BIYIKLI GENÇTÜRK Z., TÖRÜNER M., et al.
37. Ulusal Radyoloji Kongresi, Turkey, 1 - 05 November 2016, (Full Text)
2016
201623. Serum Vitamin D levels have some effects on Sexual dysfunction and health quality in Turkish IBD patients
TÖRÜNER M., Ateş E., ÇALIŞKAN KARTAL A., ÇETİNKAYA H., SOYKAN A. İ.
IMKASID 2016, 15 - 16 April 2016, (Full Text)
2015
201524. ERAP1 Gene polymorphisms in Turkish Patients with inflammatory bowel disease and ankylosing spondylitis
ÇETİNKAYA H., KALKAN Ç., KARAKAYA M. F., ÇALIŞKAN KARTAL A., KÜÇÜKŞAHİN O., BEKTAŞ M., et al.
Falk Symposium No: 200, 16 - 17 October 2015
2015
201526. Health Quality and Sexual Dysfunction in Turkish IBD Patients
TÖRÜNER M., Ateş E., KALKAN Ç., KARAKAYA M. F., ÇETİNKAYA H., SOYKAN A. İ.
ECCO, 1 - 05 February 2015
2014
201427. ASSOCIATION BETWEEN SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) IN PROSPECTIVE GENES AND SUSCEPTIBILITY TO ANKYLOSING SPONDYLITIS, INFLAMMATORY BOWEL DISEASE IN A TURKISH POPULATION
KÜÇÜKŞAHİN O., Ates A., Turkcapar N., TÖRÜNER M., Duman T., Sahin A., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, France, 11 - 14 June 2014, vol.73, pp.807, (Summary Text)
2014
201428. THE FREQUENCY OF SPONDYLOARTHROPATHY IN INFLAMMATORY BOWEL DISEASES
KÜÇÜKŞAHİN O., Ates A., TÖRÜNER M., Turkcapar N., Sahin A., Turgay M., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, France, 11 - 14 June 2014, vol.73, pp.1040, (Summary Text)
2014
201429. ERAP 1 gene polymorphisms in Turkish patients with inflammatory bowel diseases and ankylosing spondylitis
KÜÇÜKŞAHİN O., TÜRKÇAPAR N., TÖRÜNER M., DUMAN T., ÇETİNKAYA H., TURGAY T. M., et al.
ECCO 2014, 20 - 22 February 2014, vol.32, pp.631, (Summary Text)
2013
201330. Ankilozan Spondilit Ve İnflamatuvar Bağirsak Hastaliğinda Erap 1 Gen Polimorfizminin Spondiloartropati Gelişiminde Rolü
KÜÇÜKŞAHİN O., ATEŞ A., TÜRKÇAPAR N., DUMAN M. T., TÖRÜNER M., ÇETİNKAYA H., et al.
14.Ulusal romatoloji kongresi 2013, Turkey, 11 - 15 September 2013
2013
201331. Tumor necrosis factor inhibitors and acute leukemia in two cases.
Ozen M., Keskin O., KÜÇÜKŞAHİN O., Ilgen U., Topcuoglu P., Turgay M., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31, (Summary Text)
2012
201232. infamatuar bağırsak hastalarında matriks metalloproteinaz 3 matriks metalloproeinaz 9 ve metalloproteinaz 1 doku inhibitörünün spondiloartropati gelişiminde ve hastalık aktivitesindeki rolleri
ELMAS D., KÜÇÜKŞAHİN O., Türkçapar N., TÖRÜNER M., TUTKAK H., TURGAY T. M., et al.
XIII. Ulusal Romatoloji Kongresi Bildiri Özetleri Ekim 2012, Turkey, 13 - 17 October 2012, vol.4, pp.171, (Summary Text)
2012
201233. Interleukin 23 Receptor, and ATG16L1 Gene Polymorphisms in Inflammatory Bowel Diseases, and the Association With the Clinical Course
Kabacam G., Karatayli S. C., Keskin O., Bektas M., Cetinkaya H., Palabiyikoglu M., et al.
Digestive Disease Week (DDW), California, United States Of America, 19 - 22 May 2012, vol.142, (Summary Text)
2010
201034. Cost Analysis in Ankara University School of Medicine Hospitals
ESATOĞLU A. E., AĞIRBAŞ İ., DOĞANAY PAYZİNER P., GÖKTAŞ B., AKBULUT Y., özatkan y., et al.
ISPOR 13th Annual European Congress, 6 - 09 November 2010
2009
200935. Clinical and Laboratory Features of Patients with Significantly Elevated Serum Gastrin Level
Kabacam G., Bektas M., Ustun Y., Yakut M., TÖRÜNER M., Cetinkaya H., et al.
Digestive Disease Week/110th Annual Meeting of the American-Gastroenterological-Association, Illinois, United States Of America, 30 May - 04 June 2009, vol.136, (Summary Text)
2008
200836. DRUG INDUCED LIVER INJURY: A SINGLE CENTER EXPERIENCE OVER A 7-YEAR PERIOD
Bektas M., Idilmon R., Cerit T., ÇINAR K., TÖRÜNER M., Soykan I., et al.
59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Costa Rica, 31 October - 04 November 2008, vol.48, (Summary Text)
2007
200737. Bacterial and viral infections mimicking inflammatory bowel diseases
TÖRÜNER M.
Falk Symposium 159 on IBD 2007 - Achievements in Research and Clinical Practice, İstanbul, Turkey, 4 - 05 May 2007, vol.159, pp.54-59, (Full Text)
2007
200738. Comparison of chromoscopic magnifying colonoscopy and convetional colonoscopy for colorectal cancer screening: Preliminary results
Cetinkaya H., Bektas M., Kahramanoglu E., Tuzun A., Savas B., TÖRÜNER M., et al.
Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132, (Summary Text)
2007
200739. Role of magnifying chromoendoscopy in differentiating adenomatous and non-adenomatous colonic lesions
TÖRÜNER M., Cetinkaya H., Tuzun A. E., Bektas M., Kahramanoglu E., Savas B., et al.
Digestive Disease Weeking Meeting/ASGE Postgraduate Course Meeting, Washington, Kiribati, 19 - 24 May 2007, vol.132, (Summary Text)
2006
200640. Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases
Colombel J., TÖRÜNER M.
Falk Symposium 153 on Immunoregulation in Inflammatory Bowel Diseases, Berlin, Germany, 6 - 07 May 2006, vol.153, pp.85-98, (Full Text)
2006
200641. The effect of Helicobacter pylori eradication on gastroesophageal reflux, gastrointestinal symptoms and quality of life in patients with functional dyspepsia
Soykan I., Bektas M., TÖRÜNER M., Cetinkaya H., Ozden A.
Digestive Disease Week/107th Annual Meeting of the American-Gastroenterological-Association, Los-Angeles, Chile, 19 - 24 May 2006, vol.130, (Summary Text)
2006
200642. Risk factors for opportunistic infections in inflammatory bowel diseases: A case-control study
TÖRÜNER M., Loftus E. V., Colombel J. F., Orenstein R., Harmsen W. S., Zinsmeister A. R., et al.
Digestive Disease Week/107th Annual Meeting of the American-Gastroenterological-Association, Los-Angeles, Chile, 19 - 24 May 2006, vol.130, (Summary Text)
2006
200643. Chromoscopic magnifying colonoscopy for colorectal cancer screening: Is it a better tool?
Cetinkaya H., Tuzun A., Bektas M., TÖRÜNER M., ENSARİ A., Soykan I., et al.
Digestive Disease Week/107th Annual Meeting of the American-Gastroenterological-Association, Los-Angeles, Chile, 19 - 24 May 2006, vol.130, (Summary Text)
2005
200544. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
Turkcapar N., TÖRÜNER M., Soykan I., Aydintug O., Cetinkaya H., Duzgun N., et al.
69th Annual Scientific Meeting of the American-College-of-Rheumatology/40th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, California, United States Of America, 12 - 17 November 2005, vol.52, (Summary Text)
2005
200545. Loss of extracellular attachment triggers an NF-kappa B-mediated survival cascade in intestinal epithelial cells
TÖRÜNER M., Fernandez-Zapico M., Myhre G., Urrutia R., Egan L.
Digestive Disease Week Meeting/106th Annual Meeting of the American-Gastroenterological-Association, Illinois, United States Of America, 14 - 19 May 2005, vol.128, (Summary Text)
2005
200546. Does heartburn in pregnancy increase the risk of gastroesophageal reflux disease?
Dettmar P., Kitapcioglu G., TÖRÜNER M.
Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week, Illinois, United States Of America, 14 - 19 May 2005, vol.128, (Summary Text)
2005
200547. C-Jun N-terminal inhibits intestinal epithelial cell anoikis downstream of survival factor nk-kappa B
TÖRÜNER M., Egan L.
Digestive Disease Week Meeting/106th Annual Meeting of the American-Gastroenterological-Association, Illinois, United States Of America, 14 - 19 May 2005, vol.128, (Summary Text)
2004
200448. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease
TÖRÜNER M., Harewood G., Loftus E., Sandborn W., Tremaine W., Faubion W., et al.
69th Annual Scientific Meeting of the American-College-of-Gastroentrology, Florida, United States Of America, 29 October - 03 November 2004, vol.99, (Summary Text)
2004
200449. Comparison of liver functional parameters with serum fibrosis markers as predictors of severe necro-inflammation in patients with chronic hepatitis B and D
Yurdaydin C., TÖRÜNER M., Bozkaya H., Okcu-Heper A., Voelker M., Erden E., et al.
39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Berlin, Germany, 14 - 18 April 2004, vol.40, pp.133, (Summary Text)
2004
200450. Effect of interferon alpha in dextran sulfate sodium induced colitis in mice
Soykan I., TÖRÜNER M., ENSARİ A., Gecim E., Coban S., Cetinkaya H., et al.
Digestive Disease Week/105th Annual Meeting of the American-Gastroenterological-Association, Louisiana, United States Of America, 16 - 19 May 2004, vol.126, (Summary Text)
2003
200351. In Sjogren's syndrome gastroesophageal reflux disease is not related with disturbances on gastric myoelectrical activity
Turk T., Celebi A., TÖRÜNER M., Keser G., Kabasakal Y., Doganavsargil E.
Annual European Congress of Rheumatology, Lisbon, Portugal, 18 June 2003, vol.62, pp.463, (Summary Text)
2003
200352. The effect of hepatitis B virus status of the donor on the hepatitis B virus serology of the recipient after allogeneic hematopoietic cell transplantation
Idilman R., Soydan E., Arat M., TÖRÜNER M., Soykan I., Karayalcin S., et al.
38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Turkey, 29 March - 01 April 2003, vol.38, pp.146, (Summary Text)
2003
200353. The effect of Saccharomyces boulardii on gastrointestinal symptoms and Helicobacter pylori eradication in patients with functional dyspepsia
Soykan I., TÖRÜNER M., Temizkan A., Ozden A.
Digestive Disease Week 2003 Meeting/104th Annual Meeting of the American-Gastroenterological-Association, ORLANDO, FLORIDA, 17 - 22 May 2003, vol.124, (Summary Text)
2003
200354. Lamivudine prophylaxis for prevention of chemotherapy induced hepatitis B virus reactivation in hepatitis B virus carriers with hematological malignancies
Idilman R., Arat M., TÖRÜNER M., Soykan I., Karayalcin S., Soydan E., et al.
38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Turkey, 29 March - 01 April 2003, vol.38, pp.146-147, (Summary Text)
2003
200355. Two year interferon treatment of chronic delta hepatitis
Yurdaydin C., Bozkaya H., Erkan O., Karaarslan H., TÖRÜNER M., Cinar K., et al.
38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Turkey, 29 March - 01 April 2003, vol.38, pp.183-184, (Summary Text)
2002
200256. Is fatigue of cholestasis mediated by altered central serotoninergic neurotransmission?
Celik T., Goren M., Gurdal H., Cinar K., TÖRÜNER M., Degim T., et al.
11th International Symposium on Hepatic Encephalopathy and Nitrogen Metabolism, Amsterdam, Netherlands, 30 May - 01 June 2002, pp.165-171, (Full Text)
2002
200257. The efficciency of ursodeoxycholic acid in treatment of limited chronic graft versus host disease of the liver.
Arat M., Idilman R., Soydan E., TÖRÜNER M., Akan H.
44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 6 - 10 December 2002, vol.100, (Summary Text)
2002
200258. The long-term ursodeoxycholic acid treatment of chronic graft-versus-host disease of the liver.
Idilman R., Arat M., TÖRÜNER M., Soydan E., Soykan I., Erden E., et al.
53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), BOSTON, MASSACHUSETTS, 1 - 05 November 2002, vol.36, (Summary Text)
Books
2024
20241. İBH'de Ekstraintestinal Bulguların Tedaviye Etkisi
Telli P., Törüner M.
in: İnflamatuvar Bağırsak Hastalığı Uzman Görüş Raporu, AKPINAR HALE,AKYÜZ FİLİZ,ARHAN MEHMET,ÇELİK AYKUT FERHAT,HATEMİ ALİ İBRAHİM,KALKAN İSMAİL HAKKI,KAV TAYLAN,TEZEL HÜSEYİN AHMET,TÖRÜNER MURAT, Editor, İnflamatuvar Barsak Hastalıkları Derneği, İstanbul, pp.138-139, 2024
2024
20242. Crohn Hastalığında Tedavi
TELLİ P., TÖRÜNER M.
in: İnflamatuar Bağırsak Hastalıkları Uzman Görüş Raporu, AKPINAR HALE, AKYÜZ FİLİZ, ARHAN MEHMET, ÇELİK AYKUT FERHAT, HATEMİ ALİ İBRAHİM, KALKAN İSMAİL HAKKI, KAV TAYLAN, TEZEL HÜSEYİN AHMET, TÖRÜNER MURAT, Editor, İnflamatuvar Barsak Hastalıkları Derneği, pp.102-111, 2024
2022
20223. Inflammatory Bowel Disease
Törüner M.
in: Rare Causes of Stroke, Derya Uluduz,Anita Arsovska, Editor, Cambridge University Press, Cambridge (MA), USA , Cambridge, pp.92-98, 2022
Activities in Scientific Journals
2018 - Continues
2018 - ContinuesFRONTIERS IN MEDICINE
Assistant Editor/Section Editor
2019 - 2023
2019 - 2023TURKISH JOURNAL OF GASTROENTEROLOGY
Editor
Memberships and Roles in Scientific Organizations
2023 - Continues
2023 - ContinuesECCO Clinical Research Committee
Member of Science Committee
2021 - Continues
2021 - Continuesİnflamatuvar Barsak Hastalıkları Derneği
Vice President
2017 - Continues
2017 - ContinuesEuropean Crohn's and Colitis Asscoiation
Member
2017 - 2019
2017 - 2019Türk Gastroenteroloji Derneği
Secretary General
2013 - 2017
2013 - 2017ECCO
Country Representative
Peer Reviews in Scientific Publications
January 2023
January 2023FRONTIERS IN MEDICINE
Journal Indexed in SSCI
December 2022
December 2022FRONTIERS OF MEDICINE
Journal Indexed in SSCI
Congress and Symposium Activities
25 November 2025 - 30 November 2025
25 November 2025 - 30 November 202542. Ulusal Gastroenteroloji Haftası
Invited Speaker
Antalya-Turkey
25 November 2025 - 30 November 2025
25 November 2025 - 30 November 202542. Ulusal Gastroenteroloji Haftası
Moderator
Antalya-Turkey
26 September 2025 - 27 September 2025
26 September 2025 - 27 September 2025Gastroenterolojide Güncellemeler ve Ufuktakiler
Moderator
Ankara-Turkey
29 May 2025 - 01 June 2025
29 May 2025 - 01 June 202514. İnflamatuvar Barsak Hastalıkları Günleri
Moderator
İstanbul-Turkey
29 May 2025 - 01 June 2025
29 May 2025 - 01 June 202514. İBH Günleri
Moderator
İstanbul-Turkey
29 May 2025 - 01 June 2025
29 May 2025 - 01 June 202514. İBH Günleri
Moderator
İstanbul-Turkey
19 February 2025 - 22 February 2025
19 February 2025 - 22 February 2025ECCO Congress
Invited Speaker
Berlin-Germany
26 November 2024 - 01 December 2024
26 November 2024 - 01 December 202441. Ulusal Gastroenteroloji Haftası
Moderator
Antalya-Turkey
26 November 2024 - 01 December 2024
26 November 2024 - 01 December 202441. Ulusal Gastroenteroloji Haftası
Moderator
Antalya-Turkey
26 November 2024 - 01 December 2024
26 November 2024 - 01 December 202441. Ulusal Gastroenteroloji Haftası
Invited Speaker
Antalya-Turkey
30 May 2024 - 02 June 2024
30 May 2024 - 02 June 2024İnflamatuvar Barsak HAstalıkları Günleri
Invited Speaker
İstanbul-Turkey
30 May 2024 - 02 June 2024
30 May 2024 - 02 June 2024İnflamatuvar Barsak Hastalıkları Günleri
Moderator
İstanbul-Turkey
08 December 2023 - 09 December 2023
08 December 2023 - 09 December 2023Pediatrik - Yetişkin İBH Buluşması
Invited Speaker
Ankara-Turkey
31 May 2023 - 03 June 2023
31 May 2023 - 03 June 202312. Ulusal İBH Günleri
Invited Speaker
İstanbul-Turkey
31 May 2023 - 03 June 2023
31 May 2023 - 03 June 202312. Ulusal İBH Günleri
Session Moderator
İstanbul-Turkey
23 November 2022 - 27 November 2022
23 November 2022 - 27 November 2022Ulusal Gastroenteroloji Haftası
Session Moderator
Antalya-Turkey
01 June 2021 - 03 June 2021
01 June 2021 - 03 June 2021İnflamatuvar Barsak Hastalıkları Okulu
Invited Speaker
İstanbul-Turkey
05 June 2015 - 07 June 2015
05 June 2015 - 07 June 201514. Panhellenic Congress on IBD
Invited Speaker
Athens-Greece
Citations
Total Citations (SCOPUS): 4810
h-index (SCOPUS): 31
Jury Memberships
May-2023
May 2023Associate Professor Exam
Mustafa Zanyar Akkuzu Eser innceleme - Ankara University
December-2022
December 2022Appointment to Academic Staff-Assistant Professorship
Dr. Muhammet Fatih Karakaya, Doktor Öğretim Üyeliği Atama - Ankara Üniversitesi
October-2022
October 2022